The diagnostic value of cold air hyperventilation in adults with suspected asthma  by Koskela, H.O. et al.
RESPIRATORY MEDICINE (1997) 91, 470-478 
The diagnostic value of cold air hyperventilation in 
adults with suspected asthma 
H. 0. KOSKELA, S. H. R,&s;~NEN AND H. 0. TUKIAINEN 
Department of Respiratory Medicine, Kuopio University Hospital, Kuopio, Finland 
The diagnostic value of isocapnic hyperventilation of cold air (IHCA) is not fully established. All 342 
adult patients in whom IHCA had been performed because of a clinical suspicion of asthma between 
1992 and 1994 were analysed retrospectively in the authors’ hospital. In addition, 26 healthy subjects 
were recruited. According to strict criteria, the patients were divided into asthmatics and symptomatic 
non-asthmatics. For the calculations of sensitivity, specificity and accuracy, the symptomatic non- 
asthmatic group served as a control. The post-test probability of asthma after IHCA was determined for 
all the possible pre-test probabilities by applying Bayes’ theorem. A linear regression model was used to 
investigate the factors associated with the reactivity to IHCA. A single 4-min IHCA and skin prick tests 
were performed in the healthy subjects. Of the 287 patients in the final analysis, 113 were defined as 
asthmatics and 174 as symptomatic non-asthmatics. The accuracy was highest using a 9.0% fall in forced 
expiratory volume in 1 s (FEV,) as a cut-off value; the specificity was then 86.8% and the sensitivity 
31.9%. The authors found IHCA to be a useful diagnostic test only if the pre-test probability of asthma 
is between 0.30 and 0.56. The positive final diagnostic gain of IHCA is 22% at its best, but the negative 
gain is negligible for all possible pre-test probabilities. Factors associated with reactivity to IHCA were 
young age and, to a lesser extent, a history of cold-weather-associated respiratory symptoms and 
pre-challenge bronchial obstruction. If a rigid cut-off value for a positive response is used in all age 
groups, the specificity of IHCA is good but the sensitivity is unacceptably low in adults. The diagnostic 
value of IHCA might increase if age is taken into account when defining the cut-off value. 
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Introduction 
Isocapnic hyperventilation of cold air (IHCA) was 
introduced as a bronchial provocation test for the 
diagnosis of asthma in the early 1980s (1). It is 
considered safe and physiological, involving the same 
kind of mechanisms as those encountered in exercise- 
induced asthma (1,2). However, the diagnostic signifi- 
cance of a response to IHCA is not considered to be 
as clear-cut as the response to exercise (3). 
The sensitivity and specificity of IHCA in the 
diagnosis of asthma have often been studied in rather 
small groups of subjects who are known to be either 
healthy or asthmatic (1,410). There are also 
large community-based studies mainly consisting 
of healthy subjects (11,12). However, in everyday 
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practice, one is seldom confronted with symptomless 
subjects. Thus, the setting in these studies may not 
correspond to the clinical situation when one encoun- 
ters a patient with a suspicion of asthma. A large 
number of symptomatic patients with suspected 
asthma have been studied by IHCA (13) and by dry 
air hyperventilation (14), but the sensitivity and the 
specificity were not reported. 
In the present study, a large number of IHCA 
results from patients suspected to have asthma were 
reviewed against the results of the more conventional 
diagnostic procedures. The study aimed to define the 
diagnostic value of this test and to characterize the 
features of patients which might respond to it. 
Materials and Methods 
SUBJECTS 
In patients who have been referred to the authors’ 
hospital because of a clinical suspicion of asthma, the 
following tests are always performed: skin prick tests 
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to common allergens, spirometry before and after 
0.6 mg of rimiterol and an ambulatory peak expira- 
tory flow (PEF) monitoring. Other tests are con- 
sidered individually. The IHCA test is usually 
performed if a patient complains of exercise- or cold 
weather-associated respiratory symptoms. All of the 
IHCA challenges performed because of clinical 
suspicion of asthma between 1992 and 1994 in the 
authors’ hospital were reviewed. Only patients aged 
15 years or older were included. The patients’ files 
were examined thoroughly so that the follow- up was 
6-30 months after IHCA. According to the informa- 
tion in the files, the patients were defined either as 
‘asthmatics’ if strictly defined criteria were fulfilled, or 
‘symptomatic nonasthmatics’, if these criteria were 
not met. The examiner was aware of the IHCA 
results, no observer blinding was used. 
In addition, 26 healthy volunteers were recruited. 
They all were lifelong non-smokers, free from any 
respiratory symptoms, they did not show any positive 
skin prick test reactions to common allergens and had 
their forced expiratory volume in 1 s (FEV,) above 
80% of predicted. The healthy subjects gave their 
informed consent for participation in the study. 
The exclusion criteria were: a technically unsatis- 
factory IHCA challenge, anti-inflammatory treat- 
ment (oral or inhaled corticosteroids, nedocromil 
sodium, sodium cromoglycate) within 1 month before 
the IHCA and use of inhaled &agonists within 6 h 
before the IHCA (however, if a patient who had used 
/$-agonists within 6 h showed more than a 9% fall in 
FEV, after IHCA, the patient was included). Lack of 
a satisfactory ambulatory PEF monitoring was also 
an exclusion criterion. (However, if a shorter than 
desired ambulatory PEF monitoring had confirmed 
asthma or if there were some other criteria for asthma 
fulfilled, the patient was included even in the absence 
of a satisfactory ambulatory PEF monitoring). 
DEFINITIONS USED IN THE EXAMINATION OF 
THE PATIENT FILES 
Asthma 
If at least one of the following criteria was fulfilled in 
a patient with symptoms (dyspnoea or persistent 
cough) suggestive of asthma. 
(1) Two or more episodes of a significant reversibility 
of the airway obstruction in the ambulatory or 
hospital PEF monitoring. 
(2) Two or more episodes of significant variation in 
the ambulatory or hospital PEF monitoring. 
(3) Significant reversibility of airways obstruction in 
spirometry. 
(4) Significant response to exercise. 
(5) Significant response in a specific allergen chal- 
lenge. 
(6) An attack of severe asthma. 
Satisfactory ambulatory PEF monitoring (The Mini 
Wright, Clement Clarke International Ltd, U.K.] 
Always three blows on each occasion, the best two 
within 30 1 min - ‘, blows at least in the morning and 
in the evening, and the duration of the recording at 
least 2 weeks. The best PEF value of the three was 
always used for the analysis. The patients usually 
inhaled a bronchodilating drug every morning and as 
needed, repeating the blows 15-30 min after the drug. 
The first 2 days of an ambulatory PEF monitoring 
were not included to the analysis because of the 
possible learning effect. 
Hospital PEF monitoring (Wrighf peak flow meter, 
Airmed Ltd, U.K.) 
The patient spent 2-7 days in a hospital ward. Peak 
expiratory flow was recorded every 4 h by a nurse. 
Always three blows on each occasion, the best two 
within 30 1 min - ’ . The patient inhaled a broncho- 
dilating drug every morning and the blows were 
repeated 15-30 min after the drug. 
Significant reversibility of the airway obstruction in the 
ambulatory or hospital PEF monitoring 
An improvement of PEF by over 15% with a bron- 
chodilating drug, calculated as: 
(PEFpost-PEFpre) x 100 
PEFpre 
Significant variation in the ambulatory or hospital PEF 
monitoring 
A difference of over 20% between the highest PEF 
value of the day and the lowest PEF value of the day 
calculated as: 
(PEFmax-PEFmin) x 100 
PEFmax 
The post-bronchodilator blows were not included in 
these calculations. 
Significant reversibility of the airway obstruction in 
spirometry [Medikro 909, Medikro Lfd, Finland or 2200 
Pulmonary Function Laboratory, SensorMedics Ltd, 
U.S.A.) 
These spirometers were volume calibrated daily with 
a 3 1 syringe. More than a 15% increase in FEV, or 
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forced expiratory volume (FVC) after an inhalation 
of 0.6 mg of rimiterol, calculated similarly as the 
reversibility of the airway obstruction in the PEF 
monitoring. 
Significant response to exercise 
More than a 15% decrease in FEV, (Micro- 
Spirometer, Micro Medical Ltd, U.K.) volume cali- 
brated weekly with a 3 1 syringe) or PEF (Wright 
peak flow meter, Airmed Ltd, U.K.) after a bicycle or 
free- running exercise challenge, calculated as: 
(FEV, or PEFpre-FEV, or PEFpost) x 100 
FEV, or PEFpre 
Signi&ant response in a specific allergen challenge 
More than a 15% decrease in FEV, (Medikro 909, 
Medikro Ltd, Finland) or PEF (Wright peak flow 
meter, Airmed Ltd, U.K.) associated with auscul- 
table wheezing or more than a 20% decrease 
even without wheezing after inhalation (Spira@ 
Elektro 2, Hengityshoitokeskus, Finland) of allergen 
(Aquagen@ SQ, ALK Laboratories, Denmark). The 
decrease was calculated similarly as the response to 
exercise. 
An attack of severe asthma 
A severe attack of dyspnoea demanding hospital- 
ization, associated with wheezing auscultated by 
a physician, and a clear-cut positive response to 
anti-asthma treatment. 
Afow 
Two or more at least 3 x 3 mm skin prick test reac- 
tions (Soluprick@ SQ, ALK Laboratories, Denmark) 
to common inhaled allergens. In five patients, the skin 
tests had not been performed and they were classified 
according to their history about allergic diseases 
(allergic dermatitis, allergic conjuctivitis, hay fever). 
The forced expiratory manoeuvres were always 
performed according to the recommendations by 
the American Thoracic Society (15). All pulmonary 
function results were corrected to BTPS. 
IHCA CHALLENGE 
Before IHCA, the patients were always asked 
about their medication and if they used 
&sympathomimetic drugs, the time when the last 
puffs had been taken was recorded. At least three 
technically satisfactory expiratory flow-volume 
curves were determined before the challenge 
(Medikro 909, Medikro Ltd, Finland). The challenge 
consisted of a single period of hyperventilation of 
subfreezing air using a heat exchanger (Jaeger RHES, 
Erich Jaeger GmbH & CoKG, Germany). Carbon 
dioxide (CO,) was added to the inspired air and 
the flow was calculated as follows: target minute 
ventilation x 0.05. By using the best FEV, value 
obtained before the challenge, the target minute ven- 
tilation was set to FEV, x 21 (n= 146) or FEV, x 25 
(n=141). The duration of the hyperventilation was 3 
(n=34) or 4 min (n=253). In the healthy controls 
(n=26), the target minute ventilation was set to 
FEV, x 25 and the duration was 4 min. At the 
inspiratory port of the mouthpiece, 8 cm from the 
mouth, the temperature of the inspired air was moni- 
tored (GTH 1200 Digitalthermometer, Greisninger 
electronic, Germany), mean - 13*5”C (range - 7.5- 
- 17) during the hyperventilation. After the end of 
hyperventilation, at least two technically satisfactory 
expiratory flow-volume curves were determined at 
3, 5 and 10min. The larger of the two FEV, 
values obtained at one sitting was recorded. The 
maximal percentage fall in FEV, in proportion to 
the best pre-challenge FEV, was used to express the 
response. 
STATISTICAL ANALYSIS 
A multiple linear regression model was used to ana- 
lyse the influence of various factors simultaneously in 
all patients. The dependent variable was the response 
to IHCA. The independent variables were age, smok- 
ing habits, the presence of cold-weather-associated 
symptoms, the presence of exercise-associated symp- 
toms, atopy and the level of pre-challenge bronchial 
obstruction expressed as FEV,% of predicted. Analy- 
sis of variance (ANOVA) was used to compare the 
responses between the groups and, if a significant 
difference existed, the groups were further compared 
by Student’s unpaired t-test. This test was also used 
to study the effects of the slight differences in the 
duration and the intensity of the challenge on the 
responses. 
The responses of the healthy group were used to 
calculate the cut-off value for an abnormal response 
as follows: mean response +~sD. This and several 
other cut-off values were used for the calculations of 
sensitivity specificity, and accuracy (16). 
Sensitivity 
Asthmatics with a positive result to IHCA x 100 
All asthmatics 
COLD AIR HYPERVENTILATION 473 







Age (years) 42.9 * 15.8 42.4 i 15.2 45.0 zt 14.9 
Men (‘l/o) 42.3 40.2 31.0 
Smokers (o/o) 21.3 33.9 
Atopy (%) 27.0 31.0 
Cold symptoms (o/o) 63.2 74.3 
Exercise symptoms (%) 77.0 78.8 
FEV, (% predicted) 96.1 * 10.1 93.5 h 13.2 86.4 i 12.2 
Values are means and standard deviations. SNA, symptomatic non-asthmatics; smokers, 
ex- or current smokers; cold symptoms, history of cold-weather-associated dyspnoea or 
cough; exercise symptoms, history of exercise-associated dyspnoea or cough. 
Specificity Results 
Symptomatic non-asthmatics with a negative 
result to IHCA x 100 
All symptomatic non-asthmatics 
Accuracy 
(Test-positive asthmatics + test-negative 
symptomatic nonasthmatics) x 100 
All patients 
Between 1992 and 1994, a total of 342 IHCA chal- 
lenges were performed due to cough and/or dyspnoea 
which had evoked a clinical suspicion of asthma. Five 
patient files could not be found and 50 patients had to 
be excluded because of the reasons stated above. 
Thus, 287 patients remained for the final analysis. 
Of these, 91% had a history of either exercise- or 
cold-weather-associated respiratory symptoms. 
With the cut-off value giving the best accuracy, the 
post-test probability of asthma was determined after 
a positive (PPV) or negative (1 -NPV) challenge result 
and the post-test probability of non-asthma (NPV) 
was determined after a negative challenge result 
for all the possible pre-test probabilities of asthma 
according to Bayes’ theorem (17): 
PPV = gP 
gP + U-m-P) 
The criteria for asthma were fulfilled in 113 
patients. In 98 patients, the diagnosis was confirmed 
by the ambulatory PEF monitoring. The mean dura- 
tion of the ambulatory PEF monitoring was 5.2 + 0,2 
weeks. In seven patients, the diagnosis was confirmed 
by hospital PEF monitoring, in six by spirometry, in 
two by exercise tests, in three by specific allergen 
challenges and in five by attacks of severe asthma. In 
eight patients, more than one criterion had been 
fulfilled. 
.fu-P) NPV=p 
.01-P) + (l-811, 
In these equations, p is the pre-test probability, the 
clinical estimate of asthma, expressed in fractional 
terms, before the test results are known.fis specificity 
and g is sensitivity, again expressed in fractional 
terms. PPV represents positive predictive value and 
NPV represents negative predictive value. The differ- 
ence between PPV or I-NPV and pre-test probability 
is the positive or negative final diagnostic gain of 
the test. 
The criteria for asthma were not met in 174 
patients, defined thus as ‘symptomatic non- 
asthmatics’. In the majority of ‘symptomatic non- 
asthmatics’ (90%) no definitive diagnosis could be 
made; they usually had transient cough or dyspnoea 
of unknown origin. The basic characteristics of the 
subjects are shown in Table 1. 
All figures in the results section are means and 
standard errors unless otherwise stated. P value 
~0.05 was accepted as the level of significance. 
Isocapnic hyperventilation of cold air was well 
tolerated. The bronchoconstriction was invariably 
responsive to a &sympathomimetic drug via a 
metered-dose inhaler. The slight differences in the 
duration (P=O.93) and the intensity (P=O.17) of the 
challenges did not affect the responses significantly. 
The responses of the healthy subjects, symptomatic 
non-asthmatics and asthmatics are presented in Fig 1. 
The following factors were associated with respon- 
siveness to IHCA: young age [partial f=23.2, 













Asthmatics SNA Healthv 
=NS I 
I 
-2.9 f 0.4% 
4.2: 0.4% 
4- 
FIG. 1. The falls in FEV, induced by isocapnic 
hyperventilation of cold air in 113 asthmatic, 174 
symptomatic non-asthmatic (SNA) and 26 healthy 
subjects. P~O.001 between the three groups 
(ANOVA). *P<O.OOl between the asthmatic and 
symptomatic non-asthmatic subjects (unpaired 
t-test). There was no significant difference between 
the symptomatic non-asthmatic and the healthy 
subjects (unpaired t-test). 
PcO.001, Fig. 2(a-c)], a history of cold-weather- 
associated respiratory symptoms (partial f= 7.4, 
PcO.01) and pre-challenge bronchial obstruction, 
expressed as FEV,% of predicted (partial fz6.0, 
P<O-05). Atopy, smoking habits and a history of 
exercise-associated symptoms did not have any 
statistically significant association. 
The specificity, sensitivity and accuracy of IHCA 
are expressed in Table 2(a). It can be seen that the 
cut-off value giving the best accuracy was a 9% fall in 
FEV, . Since there was a clear association between the 
response and age, these values were also calculated 
separately for patients under 40 years of age and for 
patients above that age [Table 2(b,c)]. A receiver 
operator characteristic curve (ROC) was constructed 
by using the false-positive (1 -specificity) and sensitiv- 
ity values for various cut-off values (Fig. 3). It can be 
seen that the cutoff value giving the best combination 
of sensitivity and specificity was a 4% fall in FEV,. 
Finally, the cut-off value calculated using the 
responses of the healthy group was a 7.3% fall in 
FEV,. All responses in the healthy group were below 
this value. 
Using the cut-off value of 9% fall in FEV,, the 
post-test probability of asthma and non-asthma, tak- 
ing into account all the pre-test probabilities were 
calculated (Fig. 4). The best results of the test (PPV: 
0.64 and NPV: 0.64) were obtained when pre-test 
probability was 0.42, that is, near the pre-test 
probability of the present study (113 asthmatics 
among 287 patientsz0.39). The interval security of 
the test (the pre-test probability range when PPV and 
NPV were both greater than 50%) was between 0.30 
and 0.56. 
Post-test probabilities of asthma after a positive 
(PPV) or negative (l- NPV) test result are expressed 
in Fig. 5. The maximal positive (0.22) and negative 
(0.06) final gains were achieved when pre-test prob- 
abilities of asthma were 0.4 and 0.5, respectively. 
All 31 patients with a greater than 7.3% fall in 
FEV, after IHCA but not fulfilling the criteria for 
asthma were further reviewed. Of them, 21 fulfilled 
the following criteria: a history of dyspnoea associ- 
ated with wheezing and a clear-cut symptomatic relief 
with inhaled /?,-sympathomimetic drugs. They were 
defined as ‘probable asthmatics’ [Fig. 2(b)]. Of the 
21 ‘probable asthmatics’, 20 had a history of cold 
weather-associated respiratory symptoms. However, 
for the purposes of calculations of specificity, sensi- 
tivity and accuracy, these patients were always 
classified as ‘symptomatic non-asthmatics’. 
Discussion 
Usually, when a new diagnostic test is evaluated, the 
diagnosis is verified against a ‘gold standard’. Unfor- 
tunately, there is no ‘gold standard’ for the diagnosis 
of asthma. However, some strict criteria for asthma 
had to be used to be able to calculate sensitivity and 
specificity of IHCA. The authors’ criteria for asthma 
fulfil the recommendations of the European Respir- 
atory Society (l&19) and the American Thoracic 
Society (20). Nevertheless, they are more or less 
arbitrary, and open to criticism. In this study, the 
majority of diagnoses were confirmed by ambulatory 
PEF monitoring. 
To definitely rule out mild asthma in a sympto- 
matic patient may be even more difficult than to 
diagnose asthma. In this study, asthma was ruled out 
in ‘symptomatic non-asthmatics’ mainly by a techni- 
cally satisfactory ambulatory PEF monitoring of at 
least 2 weeks, though usually of 5 weeks duration, in 
which no signs of spontaneous diurnal PEF variation 
or significant responses to bronchodilating drugs 
could be found. However, it is well known that 
there may be only minor fluctuations in PEF values 
in subjects with mild asthmatic symptoms (21). 
Accordingly, a subgroup in this study with 
wheezing dyspnoea, symptomatic benefit from &- 
sympathomimetic drugs and positive responses to 
IHCA could be identified among the patients not 
fulfilling the criteria for asthma. 
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FIG. 2. The relation of the response to age in asthmatic (a), symptomatic non-asthmatic (b), and healthy 
subjects (c) with regression lines. In (b), 0 indicate the ‘probable asthmatics’ (see text). 
The cut-off value for the abnormal response is of 
major importance when interpreting the results; the 
greater it is, the greater is specificity, but the sensitiv- 
ity decreases, and vice versa. The receiver operator 
curve suggested a 4% fall in FEV, as a cut-off value 
which gives the best compromise between sensitivity 
and specificity (62.8 and 60.9%, respectively). How- 
ever, this is not necessarily what a clinician needs. 
Isocapnic hyperventilation of cold air is usually used 
as a confirmation test and it should thus have high 
nosologic specificity (17). In addition, a 4% change in 
FEV, is smaller than the within- day coefficient of 
variation for repeated measurements of FEV, which 
is about 8% in patients with obstructive lung diseases 
(22). The same arguments apply in part against the 
use of a 7.3% fall as a cut-off level. However, the 9% 
fall in FEV,, which gave the best accuracy in this 
study, meets the above-mentioned criteria. In 
addition, it has been used in numerous previous 
studies (1,3,7,11,12), allowing comparison between 
them and the present study. Due to these reasons, the 
Bayesian analysis was done using the 9% fall in FEV, 
as a cut-off value. Using this cut- off value, a specifi- 
city of 87% and a sensitivity of 32% were determined 
in a large group of symptomatic patients. 
The specificity of IHCA has also been good in 
previous studies, often even better than found by the 
present authors’. This is not surprising as, in the 
earlier studies, pre-selected, definitely healthy control 
groups have been used for the calculations of specifi- 
city (1,5,7,&l 0). If the present authors had calculated 
the specificity using the healthy group as control, it 
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TABLE 2. The specificity, sensitivity and accuracy of 
IHCA using various cutoff values: (a) all patients 
(n=287); (b) patients under 40 years of age (n= 115); 
(c) patients 40 years or older (n= 172) 
Cutoff value Specificity Sensitivity Accuracy 









75.3 47.8 64.5 
82.2 37.2 64.5 
85.1 33.6 64.8 
86.8 31.9 65.2 
87.9 28.3 64.5 
89.7 23.9 63.8 









74.3 51.2 66.1 
78.4 48.8 67.8 
81.1 43.9 67.8 
83.8 39.0 67.8 
85.1 39.0 68.7 
85.1 34.2 67.0 
87.8 31.7 67.8 
(4 
4.0 72.0 52.8 64.0 
5.0 80.0 45.8 65.7 
6.0 88.0 38.9 67.4 
7.0 90.0 30.6 65.1 
8.0 93.0 23.6 64.0 
9.0 93.0 22.2 63.4 
10.0 93.0 19.4 62.2 
would have been 100% even using the 7.3% fall in 
FEV, as a cut-off value. This study extends the 
findings of earlier studies in showing that the specifi- 
city of IHCA is good even if patients with various 
respiratory symptoms, but without asthma, are used 
as controls. 
The low sensitivity of IHCA was a disappointment 
in this study since it has been 85-100% in most earlier 
studies (1,4,6,7,9). This discrepancy cannot be 
explained on the basis of stimulus intensity since the 
ventilation levels and the durations of the challenges 
in these studies were comparable with those in this 
study. However, in these earlier studies, the asthmat- 
ics have been much younger than those in this study: 
mean 24, 25, 11, 12 and 12 years old, respectively, 
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FIG. 3. Receiver operator curve for different cut-off 
values of isocapnic hyperventilation of cold air. 
I I I I I I I I \ 
0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 
Pre-test probability 
FIG. 4. Curves for positive (0) and negative (0) 
predictive values of isocapnic hyperventilation of 
cold air for all the possible pre-test probabilities 
using a cut-off value of 9% fall in FEV,. 
whereas in this study, the asthmatics were (mean) 
45 years old. As the responsiveness to IHCA in this 
study was found to be strongly associated with young 
age, the good responsiveness to IHCA in the earlier 
studies may be explained by the young age of the 
patients. It is worthy of note that in two large 
population-based studies, only 22-31% (12) or 43% 
(11) of those with a doctor’s diagnosis of asthma 
responded to IHCA. 
Although sensitivity and specificity are good 
markers of the diagnostic quality of the test, its 
clinical and epidemiological usefulness can only 
be established by taking into account the prior 
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FIG. 5. Post-test probability of asthma after a 
positive (0) or negative (0) isocapnic hyperventila- 
tion of cold air (IHCA) response for all the possible 
pre-test probabilities using a cut-off value of 9% fall 
in FEV,. G( +), maximal positive final diagnostic 
gain of IHCA; G( - ), maximal negative final 
diagnostic gain of IHCA. 
probability of disease. The prior probability of the 
disease in clinical setting is based on history, physical 
examination and laboratory data of the patient. In 
epidemiological studies, it is based on the estimation 
about the prevalence of the disease in population. In 
the present study, the pre-test probability was taken 
into account by applying Bayes’s theorem (17), as did 
Perpifia et al. on methacholine test (23). 
The results from the Bayesian analysis show that 
IHCA is a useful test only when the pre-test prob- 
ability is between 0.30 and 0.56, which is a very 
narrow range. Thus, it may not be an useful test in 
population-based epidemiological studies where the 
estimated prevalence of asthma is much lower than 
0.30 (24). Likewise, if a physician’s estimate of 
asthma is greater than 0.56, the test may not help the 
clinician significantly in the diagnostics of asthma. 
The Bayesian analysis also showed how much 
IHCA can increase or decrease the pre-test prob- 
ability of asthma after a positive or negative response. 
This was called the final diagnostic gain of the test. 
The maximal positive gain of IHCA, 0.22, is achieved 
when pre-test probability is 0.4. This is an acceptable, 
although not an impressive, value. However, even in 
an ideal clinical setting, a negative response to IHCA 
makes the post-test probability of asthma only 6% 
less than the pre-test probability, a change without 
any clinical value. 
These results suggest that IHCA may not be 
a useful tool for screening adult patients with 
symptoms indicative of asthma. In order to find the 
subgroup of patients in which this test should be 
performed, the authors tried to characterize the 
patients who responded to IHCA. Such features were 
found to be: young age (especially) and, to a lesser 
extent, a presence of cold-weather-associated respir- 
atory symptoms and a pre-challenge bronchial 
obstruction. A similar association between young age 
and responsiveness to IHCA has been described 
before (11,12). If a rigid cut-off value is used for all 
age groups, IHCA may be a useful test only for young 
patients, especially children. However, when age was 
taken into account when defining the cut-off value for 
a positive response, IHCA was found to be equally 
useful in all age groups, and both the sensitivity and 
the accuracy increased. For patients younger than 
40 years, a 12% fall in FEV, was a suitable cut-off 
value, whereas for patients 40 years or older, a fall as 
small as 6”/ was suitable. Of course, such a crude 
division into two age groups is not physiological. A 
better way would be to create a cut-off value which 
changes continuously with age. To be able to calcu- 
late the formula for that, a large study applying 
IHCA on healthy patients of a wide age range should 
be carried out. 
The study’s IHCA protocol was originally designed 
according to the recommendations of Assoufi et al. 
(25). They found that the maximal response to IHCA 
can be achieved with a single challenge of 3 min 
duration at a minute ventilation rate of FEV, x 21. 
The authors lengthened the challenge to 4 min and 
increased the ventilation to FEV, x 25 in order to 
increase the sensitivity. However, these changes did 
not affect the responses significantly. The present 
results thus support the view of Assoufi et ul. (25). 
The present study may be criticized on the basis 
of the selection bias. Indeed, 91% of the patients 
had a history of either exercise- or cold-weather- 
associated respiratory symptoms. However, the 
prevalence of exercise-induced symptoms in patients 
with asthma has been reported to range from 
40-90X (2). In addition, almost 70% of the asthmatic 
patients report cold weather to be a factor causing 
breathing difficulties (26). Thus, the present study’s 
patient material was not markedly skewed in these 
respects. 
In conclusion, IHCA appears to be a specific, 
although not a sensitive, test for the diagnosis of 
asthma in adult patients. This makes the diagnostic 
value of this test questionable for all the possible 
pre-test probabilities of asthma. However, as the 
responsiveness to IHCA was strongly associated with 
age, its diagnostic value might increase if age is taken 
into account when defining the cut-off value for a 
positive response. 
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